Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Resveratrol attenuates TNBC lung metastasis by down-regulating PD-1 expression on pulmonary T cells and converting macrophages to M1 phenotype in a murine tumor model
Xu Han, Na Zhao, Wenwen Zhu, et al.
Cellular Immunology (2021) Vol. 368, pp. 104423-104423
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets
Zhangfeng Zhong, Chi Teng Vong, Feiyu Chen, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 3, pp. 1246-1279
Open Access | Times Cited: 75
Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives
Xiaoli Shi, Xinyi Wang, Wentao Yao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 33
The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy
Dongming Li, Donghui Cao, Yuanlin Sun, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 16
Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action
Mitra Behroozaghdam, Maryam Dehghani, Amirhossein Zabolian, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 11
Closed Access | Times Cited: 40
Remodeling tumor microenvironment with natural products to overcome drug resistance
Wanlu Zhang, Shubo Li, Chunting Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 40
Tumor-associated Macrophages (TAMs) in Cancer Resistance; Modulation by Natural Products
Holya A. Lafta, Ali Hamid AbdulHussein, Saif A. J. Al-Shalah, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 12, pp. 1104-1122
Closed Access | Times Cited: 39
Resveratrol improves the cytotoxic effect of CD8 +T cells in the tumor microenvironment by regulating HMMR/Ferroptosis in lung squamous cell carcinoma
Gao Shan, Minchao Kang, Wang Jizhao, et al.
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 229, pp. 115346-115346
Closed Access | Times Cited: 31
Immunoregulation by resveratrol; implications for normal tissue protection and tumour suppression
Armineh Rezagholi Lalani, Fatemeh Fakhari, Shakila Radgoudarzi, et al.
Clinical and Experimental Pharmacology and Physiology (2023) Vol. 50, Iss. 5, pp. 353-368
Closed Access | Times Cited: 29
Nanotechnology-mediated delivery of resveratrol as promising strategy to improve therapeutic efficacy in triple negative breast cancer (TNBC): progress and promises
Javed Ahmad, Javed Ahamad, Mohammed S. Algahtani, et al.
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 2, pp. 229-244
Closed Access | Times Cited: 9
Resveratrol in Cancer Therapy: From Stimulation of Genomic Stability to Adjuvant Cancer Therapy: A Comprehensive Review
Peyman Amini, Reza Moazamiyanfar, Mohammad Sedigh Dakkali, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 23, Iss. 8, pp. 629-648
Closed Access | Times Cited: 32
T lymphocyte cell: A pivotal player in lung cancer
Yanan Wu, Meng Yuan, Chenlin Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
Active Ingredients from Chinese Medicine for Combination Cancer Therapy
Xuan Wang, Jing Li, Ruie Chen, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 11, pp. 3499-3525
Open Access | Times Cited: 19
Active ingredients of traditional Chinese medicine for enhancing the effect of tumor immunotherapy
Chao Yang, Dan Li, Chung‐Nga Ko, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Enhanced drug release from a pH-responsive nanocarrier can augment colon cancer treatment by blocking PD-L1 checkpoint and consuming tumor glucose
Kai Guo, Yixuan Liu, Min Ding, et al.
Materials & Design (2022) Vol. 219, pp. 110824-110824
Open Access | Times Cited: 24
Nature’s Arsenal: Harnessing the Capacity of Phytochemicals to Enhance Immune Checkpoint Inhibitor Therapy of Cancers: An Especial Attention to Brain Malignancies
Amir R. Afshari, Mehdi Sanati, Seyed Sajad Ahmadi, et al.
Cancer Letters (2024) Vol. 593, pp. 216955-216955
Closed Access | Times Cited: 5
From mundane to classic: Sinomenine as a multi‐therapeutic agent
Dan Li, Zhangfeng Zhong, Chung‐Nga Ko, et al.
British Journal of Pharmacology (2023)
Closed Access | Times Cited: 12
Targeting the prostate tumor microenvironment by plant-derived natural products
Jiacheng Wu, Hao Ji, Tiantian Li, et al.
Cellular Signalling (2023) Vol. 115, pp. 111011-111011
Closed Access | Times Cited: 11
Nano-formulated delivery of active ingredients from traditional Chinese herbal medicines for cancer immunotherapy
Qi Shang, Wandong Liu, Faith Leslie, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 4, pp. 1525-1541
Open Access | Times Cited: 11
Targeting the breast tumor microenvironment by plant-derived products and their nanoformulations
Hongpeng Zhang, Yanshu Li
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105432-105432
Closed Access | Times Cited: 3
Effect of boswellic acids on the expression of PD-1 and TIGIT immune checkpoints on activated human T cells
Abdo Meyiah, Ahmed Al‐Harrasi, Najeeb Ur Rehman, et al.
Fitoterapia (2025) Vol. 181, pp. 106401-106401
Closed Access
Exploiting the immune system in hepatic tumor targeting: Unleashing the potential of drugs, natural products, and nanoparticles
Chou‐Yi Hsu, Mohammed Ahmed Mustafa, Ashwani Kumar, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155266-155266
Closed Access | Times Cited: 3
Resveratrol and Its Analogue 4,4′-Dihydroxy-trans-stilbene Inhibit Lewis Lung Carcinoma Growth In Vivo through Apoptosis, Autophagy and Modulation of the Tumour Microenvironment in a Murine Model
Monica Savio, Alessandra Ferraresi, Chiara Corpina, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1784-1784
Open Access | Times Cited: 14
Modulatory Role of Phytochemicals/Natural Products in Cancer Immunotherapy
Yadu Vijayan, Jaskirat Singh Sandhu, Kuzhuvelil B. Harikumar
Current Medicinal Chemistry (2024) Vol. 31, Iss. 32, pp. 5165-5177
Closed Access | Times Cited: 2
β,β-Dimethylacrylalkannin, a Natural Naphthoquinone, Inhibits the Growth of Hepatocellular Carcinoma Cells by Modulating Tumor-Associated Macrophages
Lisha Shen, Zesi Lin, Rui‐Hong Gong, et al.
Molecules (2024) Vol. 29, Iss. 16, pp. 3919-3919
Open Access | Times Cited: 2
Current Advancements of Plant-Derived Agents for Triple-Negative Breast Cancer Therapy through Deregulating Cancer Cell Functions and Reprogramming Tumor Microenvironment
Tai-Na Wu, Hui-Ming Chen, Lie‐Fen Shyur
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13571-13571
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top